Carnegie Capital Asset Management LLC Acquires 413 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Carnegie Capital Asset Management LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,200 shares of the healthcare conglomerate’s stock after purchasing an additional 413 shares during the quarter. Carnegie Capital Asset Management LLC’s holdings in UnitedHealth Group were worth $22,217,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in UNH. Moneta Group Investment Advisors LLC raised its stake in UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter valued at $5,210,004,000. Arrowstreet Capital Limited Partnership raised its stake in UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after buying an additional 2,540,538 shares during the last quarter. International Assets Investment Management LLC raised its stake in UnitedHealth Group by 53,573.1% during the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after buying an additional 2,348,107 shares during the last quarter. Finally, Barclays PLC raised its stake in UnitedHealth Group by 143.4% during the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after buying an additional 2,058,829 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.6 %

Shares of NYSE UNH traded down $2.52 during midday trading on Friday, hitting $439.20. The company’s stock had a trading volume of 6,045,671 shares, compared to its average volume of 4,111,728. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The business’s 50 day moving average is $492.29 and its two-hundred day moving average is $516.25. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a market cap of $404.91 billion, a P/E ratio of 18.42, a price-to-earnings-growth ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. During the same period in the prior year, the business posted $5.34 earnings per share. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.71%. UnitedHealth Group’s payout ratio is currently 31.54%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Stephens restated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Barclays assumed coverage on UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target for the company. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Morgan Stanley reduced their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Three research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $576.48.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.